The average P/S ratio for AXSM's competitors is 43.41, providing a benchmark for relative valuation. Axsome Therapeutics Inc Corp (AXSM) exhibits a P/S ratio of 8.33, which is -80.81% above the industry average. Given its robust revenue growth of 61.95%, this premium appears sustainable.